Unknown

Dataset Information

0

Programmed surface on poly(aryl-ether-ether-ketone) initiating immune mediation and fulfilling bone regeneration sequentially.


ABSTRACT: The immune responses are involved in every stage after implantation but the reported immune-regulated materials only work at the beginning without fully considering the different phases of bone healing. Here, poly(aryl-ether-ether-ketone) (PEEK) is coated with a programmed surface, which rapidly releases interleukin-10 (IL-10) in the first week and slowly delivers dexamethasone (DEX) up to 4 weeks. Owing to the synergistic effects of IL-10 and DEX, an aptly weak inflammation is triggered within the first week, followed by significant M2 polarization of macrophages and upregulation of the autophagy-related factors. The suitable immunomodulatory activities pave the way for osteogenesis and the steady release of DEX facilitates bone regeneration thereafter. The sequential immune-mediated process is also validated by an 8-week implementation on a rat model. This is the first attempt to construct implants by taking advantage of both immune-mediated modulation and sequential regulation spanning all bone regeneration phases, which provides insights into the fabrication of advanced biomaterials for tissue engineering and immunological therapeutics.

SUBMITTER: Xie L 

PROVIDER: S-EPMC8454576 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Programmed surface on poly(aryl-ether-ether-ketone) initiating immune mediation and fulfilling bone regeneration sequentially.

Xie Lingxia L   Wang Guomin G   Wu Yuzheng Y   Liao Qing Q   Mo Shi S   Ren Xiaoxue X   Tong Liping L   Zhang Wei W   Guan Min M   Pan Haobo H   Chu Paul K PK   Wang Huaiyu H  

Innovation (Cambridge (Mass.)) 20210805 3


The immune responses are involved in every stage after implantation but the reported immune-regulated materials only work at the beginning without fully considering the different phases of bone healing. Here, poly(aryl-ether-ether-ketone) (PEEK) is coated with a programmed surface, which rapidly releases interleukin-10 (IL-10) in the first week and slowly delivers dexamethasone (DEX) up to 4 weeks. Owing to the synergistic effects of IL-10 and DEX, an aptly weak inflammation is triggered within  ...[more]

Similar Datasets

| S-EPMC10305048 | biostudies-literature
| S-EPMC9269289 | biostudies-literature
| S-EPMC8199459 | biostudies-literature
| S-EPMC8680496 | biostudies-literature
| S-EPMC6299303 | biostudies-literature
| S-EPMC11835654 | biostudies-literature
| S-EPMC8698150 | biostudies-literature
| S-EPMC10880674 | biostudies-literature
| S-EPMC8288931 | biostudies-literature
| S-EPMC9699565 | biostudies-literature